These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 22042912)
1. Fever induction by systemic stimulation with macrophage-activating lipopeptide-2 depends upon TLR2 but not CD36. Welsch J; Hübschle T; Murgott J; Kirschning C; Rummel C; Gerstberger R; Roth J Innate Immun; 2012 Jun; 18(3):541-59. PubMed ID: 22042912 [TBL] [Abstract][Full Text] [Related]
2. Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever. Knorr C; Hübschle T; Murgott J; Mühlradt P; Gerstberger R; Roth J Brain Res; 2008 Apr; 1205():36-46. PubMed ID: 18353287 [TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses. Deiters U; Gumenscheimer M; Galanos C; Mühlradt PF Infect Immun; 2003 Aug; 71(8):4456-62. PubMed ID: 12874325 [TBL] [Abstract][Full Text] [Related]
4. Peripheral and central cyclooxygenase (COX) products may contribute to the manifestation of brain-controlled sickness responses during localized inflammation induced by macrophage-activating lipopeptide-2 (MALP-2). Knorr C; Marks D; Gerstberger R; Mühlradt PF; Roth J; Rummel C Neurosci Lett; 2010 Jul; 479(2):107-11. PubMed ID: 20580659 [TBL] [Abstract][Full Text] [Related]
5. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. Sato S; Nomura F; Kawai T; Takeuchi O; Mühlradt PF; Takeda K; Akira S J Immunol; 2000 Dec; 165(12):7096-101. PubMed ID: 11120839 [TBL] [Abstract][Full Text] [Related]
6. Effects of repeated injections of fibroblast-stimulating lipopeptide-1 on fever, formation of cytokines, and on the responsiveness to endotoxin in guinea-pigs. Greis A; Murgott J; Gerstberger R; Hübschle T; Roth J Acta Physiol (Oxf); 2009 Sep; 197(1):35-45. PubMed ID: 19309391 [TBL] [Abstract][Full Text] [Related]
7. Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1. Hübschle T; Mütze J; Mühlradt PF; Korte S; Gerstberger R; Roth J Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R180-7. PubMed ID: 16154916 [TBL] [Abstract][Full Text] [Related]
8. Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides. Satta N; Kruithof EK; Reber G; de Moerloose P Mol Immunol; 2008 Nov; 46(1):145-57. PubMed ID: 18722665 [TBL] [Abstract][Full Text] [Related]
9. Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs. Barrenschee M; Lex D; Uhlig S PLoS One; 2010 Nov; 5(11):e13889. PubMed ID: 21124967 [TBL] [Abstract][Full Text] [Related]
10. CD36 is a sensor of diacylglycerides. Hoebe K; Georgel P; Rutschmann S; Du X; Mudd S; Crozat K; Sovath S; Shamel L; Hartung T; Zähringer U; Beutler B Nature; 2005 Feb; 433(7025):523-7. PubMed ID: 15690042 [TBL] [Abstract][Full Text] [Related]
11. NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. Schuett J; Schuett H; Oberoi R; Koch AK; Pretzer S; Luchtefeld M; Schieffer B; Grote K FASEB J; 2017 Jun; 31(6):2612-2624. PubMed ID: 28274989 [TBL] [Abstract][Full Text] [Related]
12. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? Galanos C; Gumenscheimer M; Mühlradt P; Jirillo E; Freudenberg M J Endotoxin Res; 2000; 6(6):471-6. PubMed ID: 11521073 [TBL] [Abstract][Full Text] [Related]
13. Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2. Sawahata R; Shime H; Yamazaki S; Inoue N; Akazawa T; Fujimoto Y; Fukase K; Matsumoto M; Seya T Microbes Infect; 2011 Apr; 13(4):350-8. PubMed ID: 21172450 [TBL] [Abstract][Full Text] [Related]
14. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561 [TBL] [Abstract][Full Text] [Related]
15. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. Cabanski M; Steinmüller M; Marsh LM; Surdziel E; Seeger W; Lohmeyer J Am J Respir Cell Mol Biol; 2008 Jan; 38(1):26-31. PubMed ID: 17690330 [TBL] [Abstract][Full Text] [Related]
16. IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells. Geisel J; Kahl F; Müller M; Wagner H; Kirschning CJ; Autenrieth IB; Frick JS J Immunol; 2007 Nov; 179(9):5811-8. PubMed ID: 17947654 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung. Schill T; Schön MP; Pletz N; Emmert S; Schön M Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500 [TBL] [Abstract][Full Text] [Related]
18. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes. Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620 [TBL] [Abstract][Full Text] [Related]
20. Resistance to endotoxin shock in spontaneously hypertensive rats. Bernard C; Merval R; Esposito B; Tedgui A Hypertension; 1998 Jun; 31(6):1350-6. PubMed ID: 9622153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]